Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,417 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT01744626

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Horizon Oncology Research, Inc Lafayette, Indiana, United States
  • Hackensack UMC Hackensack, New Jersey, United States
  • The West Clinic Memphis, Tennessee, United States
View Trial Details
Completed

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

NCT01275196

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Chengdu, Sichuan, China
View Trial Details
Completed

Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response

NCT01043874

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Aomori, Japan
View all 20 locations
View Trial Details
Completed

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01410513

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +19 more
Locations
  • Investigational Site Number 840004 Aurora, Colorado, United States
  • Investigational Site Number 840006 Augusta, Georgia, United States
  • Investigational Site Number 840002 Charleston, South Carolina, United States
View Trial Details
Completed

A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)

NCT00495287

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • USC Ematologia Azienda Papa Giovanni XXIII Bergamo, BG, Italy
  • Ospedale Spedali Civili di Brescia Brescia, Italy
  • Ospedale Generale di Bolzano Bolzano, Bz, Italy
View all 17 locations
View Trial Details

Related conditions